drugset / Trial / NCT00006097

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

NCT00006097 ↗

Phase 1/2 Completed Boston Medical Center
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of CC-1088 in treating patients who have chronic lymphocytic leukemia that has not responded to previous therapy.

Timeline

Start
1999-08
Primary completion
2005-07
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CDC-801 Small molecule — Oral

Indications